about
iPSC technology-based regenerative therapy for diabetes.Adrenergic receptor agonists induce the differentiation of pluripotent stem cell-derived hepatoblasts into hepatocyte-like cells.Beta-cell replacement strategies for diabetes.Human pluripotent stem cell-derived erythropoietin-producing cells ameliorate renal anemia in mice.Insulin-producing cells derived from 'induced pluripotent stem cells' of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis-related genes.Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers.Author Correction: Development of new method to enrich human iPSC-derived renal progenitors using cell surface markersFailure to confirm a sodium-glucose cotransporter 2 inhibitor-induced hematopoietic effect in non-diabetic rats with renal anemia
P50
Q39369744-FE64386C-7987-44AE-A871-0B16B926F189Q47137465-6E5156CA-FE2B-4CD0-AF58-35A24D78F004Q47596092-BDD0B045-AB7D-47D9-B934-60213383891AQ47734807-70A6C666-4326-42F3-9D3C-B01787CAE6F5Q48259650-2BA0849D-164F-449F-A188-01EA07AF874AQ54965268-72393516-1AC1-4738-9DF9-D1CB353D5436Q91968353-D6375BBC-F460-404B-8FC2-7EAA0E90D062Q92276820-7327BFA3-3E15-4693-BC2D-D05F78B7FB48
P50
description
researcher
@en
wetenschapper
@nl
name
Kenji Osafune
@en
Kenji Osafune
@nl
type
label
Kenji Osafune
@en
Kenji Osafune
@nl
prefLabel
Kenji Osafune
@en
Kenji Osafune
@nl
P31
P496
0000-0001-7238-2763